PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 24, 2026Cardiovascular revascularization medicine0 citations

Prasugrel monotherapy versus 12-month dual antiplatelet therapy in STEMI patients undergoing intravascular imaging-guided PCI: Study design and rationale of the randomized PREMIUM trial

View Full Paper
KTKuniaki TakahashiKKKen KozumaYMYoshihiro Morino

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Takahashi et al. (2025) studied this question.

synapsesocial.com/papers/6a8c5f9f454de3f4177e7164https://doi.org/10.1016/j.carrev.2025.12.007
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Aspirin-Free Prasugrel Monotherapy After Percutaneous Coronary Intervention in Patients With Non-ST Elevation Acute Coronary Syndrome2025 · 4 citations
  2. 2Early Discontinuation of Aspirin after PCI in Low-Risk Acute Myocardial Infarction2025 · 64 citations
  3. 3Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention2015 · 454 citations
  4. 4Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial2023 · 158 citations
  5. 5Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome2020 · 582 citations